NPH insulin : It remains a good option
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
NPH insulin: It remains a good option. NPH insulin holds its own against basal insulin analogs - and it's cheaper. PRACTICE CHANGER: Consider NPH insulin for patients who require initiation of long-acting insulin therapy because it is as safe as, and more cost-effective than, basal insulin analogs. STRENGTH RECOMMENDATION: B: Based on a single, large, retrospective, observational study.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.